BAC
Bank of America Corporation
BAC has a slight edge over FRAF overall, supported by stronger valuation and stronger modeled upside.
FRAF
Franklin Financial Services Corporation
FRAF offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FRAF Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FRAF's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRAF.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | โ |
| Current | 12x | $50.51 | โ |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FRAF in the historical PE scenario, which offers more potential upside but is not a forecast.
FRAF PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $47.51 | -32% |
| Fair | 9.4x | $58.05 | -17% |
| Current | 11x | $69.78 | โ |
| Expensive | 12x | $72.26 | +3.5% |
Historical ranges are pointers, not guarantees.
FRAF's PE is in its expensive range at 11x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FRAF Forward outlook
There aren't enough analyst estimates for FRAF to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
FRAF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $6.19 | +76% |
| Q2 2026 | $5.49 | +67% |
| Q1 2026 | $5.34 | +104% |
| Q4 2025 | $4.74 | +89% |
| Q3 2025 | $3.52 | +11% |
| Q2 2025 | $3.28 | +5.8% |
| Q1 2025 | $2.62 | -16% |
| Q4 2024 | $2.51 | -19% |
FRAF earned $6.19 per share over the past year, up 76% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FRAF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.6M | +11% |
| Q2 2026 | $24.5M | +9.6% |
| Q1 2026 | $23.9M | +18% |
| Q4 2025 | $23.3M | +52% |
| Q3 2025 | $23M | +18% |
| Q2 2025 | $22.3M | +20% |
| Q1 2025 | $20.2M | +14% |
| Q4 2024 | $15.4M | -14% |
FRAF's revenue has grown year over year for seven quarters in a row: $26M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +13 points |
| Q2 2026 | 34% | +0.9 points |
| Q1 2026 | 35% | +11 points |
| Q4 2025 | 32% | +29 points |
| Q3 2025 | 29% | +2.8 points |
| Q2 2025 | 33% | +13 points |
| Q1 2025 | 24% | +1.4 points |
| Q4 2024 | 3.6% | -19 points |
FRAF has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FRAF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.7M | +30% |
| Q1 2026 | $24.1M | +173% |
| Q4 2025 | $3.2M | -25% |
| Q3 2025 | $8.3M | +6.4% |
| Q2 2025 | $5.1M | +111% |
| Q1 2025 | $8.8M | +21% |
| Q4 2024 | $4.2M | -29% |
| Q3 2024 | $7.8M | +7.5% |
FRAF has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FRAF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.0x | Very low |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | -8.8x | Net Cash |
| Q2 2025 | -10.4x | Net Cash |
| Q1 2025 | -13.9x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
FRAF has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FRAF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.0 | Neutral |
| Stochastic | 75.1 | Neutral |
FRAF's weekly RSI is 68 (neutral) and its Stochastic is 75 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FRAF PE vs Financial Services Sector
| Metric | FRAF | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 78 | 63 | 15 pts above |
FRAF has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FRAF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $65.6 | 6.4% above |
| 20 week MA | $64.0 | 9% above |
| 50 week MA | $58.0 | 20% above |
| 100 week MA | $48.8 | 43% above |
| 200 week MA | $39.3 | 78% above |
FRAF has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FRAF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.7 | $30.0 | -22% |
| 2021 | $30.0 | $33.3 | +11% |
| 2022 | $33.3 | $32.0 | -4% |
| 2023 | $32.0 | $31.6 | -1.4% |
| 2024 | $31.6 | $30.2 | -4.2% |
| 2025 | $30.2 | $51.0 | +69% |
| 2026 YTD | $51.0 | $69.8 | +37% |
FRAF has the edge over BAC on returns for 2026, with the stronger performance.